Cure MSA

Country specific patient information

Agilli M, Aydin FN, Cayci T, Kurt YG. Relationship between leptin and blood pressure in patients with multiple system atrophy. J Neurol Sci 2015;348:284.

 

Armstrong RA. Visual signs and symptoms of multiple system atrophy. Clin Exp Optom 2014;97:483-491.

 

Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL. Neuropathological features of multiple system atrophy with cognitive impairment. Mov Disord 2014;29:884-888.

 

Baeza Trinidad R, Serrano Ponz M. [Multiple system atrophy: hot cross bun and Santiaguino sign]. Rev Clin Esp (Barc) 2014;214:e9.

 

Baudrexel S, Seifried C, Penndorf B, Klein JC, Middendorp M, Steinmetz H, Grunwald F, Hilker R. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Mov Disord 2014;29:380-387.

 

Bleasel JM, Wong JH, Halliday GM, Kim WS. Lipid dysfunction and pathogenesis of multiple system atrophy. Acta Neuropathol Commun 2014;2:15.

 

Bologna M, Marsili L, Khan N, Parvez AK, Paparella G, Modugno N, Colosimo C, Fabbrini G, Berardelli A. Blinking in patients with clinically probable multiple system atrophy. Mov Disord 2014;29:415-420.

 

Brisinda D, Sorbo AR, Di Giacopo R, Venuti A, Bentivoglio AR, Fenici R. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy. J Neurol Sci 2014;336:197-202.

 

Cao B, Guo X, Chen K, Song W, Huang R, Wei QQ, Zhao B, Shang HF. Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population. Neurol Res 2014;36:150-156.

 

Caslake R, Taylor K, Scott N, Harris C, Gordon J, Wilde K, Murray A, Counsell C. Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study. Parkinsonism Relat Disord 2014;20:834-839.

 

Celebi O, Temucin CM, Elibol B, Saka E. Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy. Parkinsonism Relat Disord 2014;20:632-636.

 

Chen HC, Lirng JF, Soong BW, Guo WY, Wu HM, Chen CC, Chang CY. The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type. Cerebellum Ataxias 2014;1:17.

 

Chen J, Mills JD, Halliday GM, Janitz M. Role of transcriptional control in multiple system atrophy. Neurobiol Aging 2015;36:394-400.

 

Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. Eur J Radiol 2014;83:564-570.

 

Chen YP, Zhao B, Cao B, Song W, Guo X, Wei QQ, Yang Y, Yuan LX, Shang HF. Mutation scanning of the COQ2 gene in ethnic Chinese patients with multiple-system atrophy. Neurobiol Aging 2015;36:1222 e1227-1211.

 

Cheshire WP. Highlights in clinical autonomic neurosciences: Clinical update on multiple system atrophy. Auton Neurosci 2014;186:5-7.

 

Chia N, Kimber T, Ash D. Electroconvulsive therapy for the neurological and psychiatric manifestations of multiple system atrophy. Aust N Z J Psychiatry 2014;48:877.

 

Cilia R, Siri C, Colombo A, Pezzoli G. Multiple compulsive behaviors in multiple system atrophy: the importance of predisposition to addiction. Parkinsonism Relat Disord 2014;20:355-357.

 

Ciolli L, Krismer F, Nicoletti F, Wenning GK. An update on the cerebellar subtype of multiple system atrophy. Cerebellum Ataxias 2014;1:14.

 

Cook GA, Sullivan P, Holmes C, Goldstein DS. Cardiac sympathetic denervation without Lewy bodies in a case of multiple system atrophy. Parkinsonism Relat Disord 2014;20:926-928.

 

Cope TE, Grube M, Singh B, Burn DJ, Griffiths TD. The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease. Neuropsychologia 2014;52:73-81.

 

Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim WS. Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta Neuropathol Commun 2014;2:150.

 

Fanciulli A, Strano S, Ndayisaba JP, Goebel G, Gioffre L, Rizzo M, Colosimo C, Caltagirone C, Poewe W, Wenning GK, Pontieri FE. Detecting nocturnal hypertension in Parkinson's disease and multiple system atrophy: proposal of a decision-support algorithm. J Neurol 2014;261:1291-1299.

 

Feng JY, Huang B, Yang WQ, Zhang YH, Wang LM, Wang LJ, Zhong XL. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease? Acta Radiol 2015;56:322-328.

 

Ferguson MC, Garland EM, Hedges L, Womack-Nunley B, Hamid R, Phillips JA, 3rd, Shibao CA, Raj SR, Biaggioni I, Robertson D. SHC2 gene copy number in multiple system atrophy (MSA). Clin Auton Res 2014;24:25-30.

 

Fernagut PO, Dehay B, Maillard A, Bezard E, Perez P, Pavy-Le Traon A, Rascol O, Foubert-Samier A, Tison F, Meissner WG. Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies. Neurobiol Dis 2014;67:133-139.

 

Fernagut PO, Meissner WG, Biran M, Fantin M, Bassil F, Franconi JM, Tison F. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. Synapse 2014;68:98-106.

 

Figueroa JJ, Singer W, Parsaik A, Benarroch EE, Ahlskog JE, Fealey RD, Parisi JE, Sandroni P, Mandrekar J, Iodice V, Low PA, Bower JH. Multiple system atrophy: prognostic indicators of survival. Mov Disord 2014;29:1151-1157.

 

Flabeau O, Meissner WG, Ozier A, Berger P, Tison F, Fernagut PO. Breathing variability and brainstem serotonergic loss in a genetic model of multiple system atrophy. Mov Disord 2014;29:388-395.

 

Fujioka S, Ogaki K, Tacik PM, Uitti RJ, Ross OA, Wszolek ZK. Update on novel familial forms of Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2014;20 Suppl 1:S29-34.

 

Galpern WR. Clinical trials for multiple system atrophy. Lancet Neurol 2015;14:126-127.

 

Gatto E, Demey I, Sanguinetti A, Parisi V, Etcheverry JL, Rojas G, Wenning GK. Cognition in a multiple system atrophy series of cases from Argentina. Arq Neuropsiquiatr 2014;72:773-776.

 

Gatto E, Rodriguez-Violante M, Cosentino C, Chana-Cuevas P, Miranda M, Gallin E, Etcheverry JL, Nunez Y, Parisi V, Persi G, Vecchi C, Sanguinetti A, Alleva A, Aparcana J, Torres L, Litvan I. Pan-American Consortium of Multiple System Atrophy (PANMSA). A Pan-American multicentre cohort study of multiple system atrophy. J Parkinsons Dis 2014;4:693-698.

 

Ghorayeb I, Dupouy S, Tison F, Meissner WG. Restless legs syndrome in multiple system atrophy. J Neural Transm (Vienna) 2014;121:1523-1527.

 

Goldman JS, Kuo SH. Multiple system atrophy and repeat expansions in C9orf72--reply. JAMA Neurol 2014;71:1191-1192.

 

Goldman JS, Quinzii C, Dunning-Broadbent J, Waters C, Mitsumoto H, Brannagan TH, 3rd, Cosentino S, Huey ED, Nagy P, Kuo SH. Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72. JAMA Neurol 2014;71:771-774.

 

Guo XY, Chen YP, Song W, Zhao B, Cao B, Wei QQ, Ou RW, Yang Y, Yuan LX, Shang HF. SNCA variants rs2736990 and rs356220 as risk factors for Parkinson's disease but not for amyotrophic lateral sclerosis and multiple system atrophy in a Chinese population. Neurobiol Aging 2014;35:2882 e2881-2886.

 

Guo XY, Chen YP, Song W, Zhao B, Cao B, Wei QQ, Ou RW, Yang Y, Yuan LX, Shang HF. An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in China. Eur J Neurol 2014;21:1337-1343.

 

Heckman MG, Schottlaender L, Soto-Ortolaza AI, Diehl NN, Rayaprolu S, Ogaki K, Fujioka S, Murray ME, Cheshire WP, Uitti RJ, Wszolek ZK, Farrer MJ, Sailer A, Singleton AB, Chinnery PF, Keogh MJ, Gentleman SM, Holton JL, Aoife K, Mann DM, Al-Sarraj S, Troakes C, Dickson DW, Houlden H, Ross OA. LRRK2 exonic variants and risk of multiple system atrophy. Neurology 2014;83:2256-2261.

 

Itoh K, Kasai T, Tsuji Y, Saito K, Mizuta I, Harada Y, Sudoh S, Mizuno T, Nakagawa M, Fushiki S. Definite familial multiple system atrophy with unknown genetics. Neuropathology 2014;34:309-313.

 

Jang MS, Han JH, Park SW, Kang JM, Kang WJ. General anesthesia for a patient with multiple system atrophy. Korean J Anesthesiol 2014;67:S34-35.

 

Jecmenica-Lukic M, Petrovic IN, Pekmezovic T, Kostic VS. Clinical outcomes of two main variants of progressive supranuclear palsy and multiple system atrophy: a prospective natural history study. J Neurol 2014;261:1575-1583.

 

Jellinger KA. Neuropathology of multiple system atrophy: new thoughts about pathogenesis. Mov Disord 2014;29:1720-1741.

 

Jeon BS, Farrer MJ, Bortnick SF, Korean Canadian Alliance on Parkinson's D, Related D. Mutant COQ2 in multiple-system atrophy. N Engl J Med 2014;371:80.

 

Ji L, Zhu D, Xiao C, Shi J. Tract based spatial statistics in multiple system atrophy: a comparison between clinical subtypes. Parkinsonism Relat Disord 2014;20:1050-1055.

 

Jian F, Pan H, Zhang Z, Lin J, Chen N, Zhang L, Wu Q, Wang H, Wang Y, Cui L, Tang X. Sphincter electromyography in diabetes mellitus and multiple system atrophy. Neurourol Urodyn 2015;34:669-674.

 

Kawamoto Y, Ito H, Ihara M, Takahashi R. XIAP immunoreactivity in glial and neuronal cytoplasmic inclusions in multiple system atrophy. Clin Neuropathol 2014;33:76-83.

 

Kim M, Jung JH, Park J, Son H, Jeong SJ, Oh SJ, Cho SY, Seoul National University Experts Of Urodynamics Leading Study G. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson's disease. Parkinsonism Relat Disord 2015;21:205-210.

 

Kragh CL, Gysbers AM, Rockenstein E, Murphy K, Halliday GM, Masliah E, Jensen PH. Prodegenerative IkappaBalpha expression in oligodendroglial alpha-synuclein models of multiple system atrophy. Neurobiol Dis 2014;63:171-183.

 

Krismer F, Jellinger KA, Scholz SW, Seppi K, Stefanova N, Antonini A, Poewe W, Wenning GK. Multiple system atrophy as emerging template for accelerated drug discovery in alpha-synucleinopathies. Parkinsonism Relat Disord 2014;20:793-799.

 

Krotenkova IA, Briukhov VV, Peresedova AV, Krotenkova MV. [Atrophy of the central nervous system in multiple sclerosis: MRI-morphometry results]. Zh Nevrol Psikhiatr Im S S Korsakova 2014;114:50-56.

 

Kuzdas-Wood D, Stefanova N, Jellinger KA, Seppi K, Schlossmacher MG, Poewe W, Wenning GK. Towards translational therapies for multiple system atrophy. Prog Neurobiol 2014;118:19-35.

 

Lalich IJ, Ekbom DC, Starkman SJ, Orbelo DM, Morgenthaler TI. Vocal fold motion impairment in multiple system atrophy. Laryngoscope 2014;124:730-735.

 

Lee ST, Chu K, Jung KH, Ban JJ, Im WS, Jo HY, Park JH, Lim JY, Shin JW, Moon J, Lee SK, Kim M, Roh JK. Altered expression of miR-202 in cerebellum of multiple-system atrophy. Mol Neurobiol 2015;51:180-186.

 

Lin DJ, Hermann KL, Schmahmann JD. Multiple system atrophy of the cerebellar type: clinical state of the art. Mov Disord 2014;29:294-304.

 

Low PA, Robertson D, Gilman S, Kaufmann H, Singer W, Biaggioni I, Freeman R, Perlman S, Hauser RA, Cheshire W, Lessig S, Vernino S, Mandrekar J, Dupont WD, Chelimsky T, Galpern WR. Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2014;13:268-275.

 

Lu CF, Wang PS, Lao YL, Wu HM, Soong BW, Wu YT. Medullo-ponto-cerebellar white matter degeneration altered brain network organization and cortical morphology in multiple system atrophy. Brain Struct Funct 2014;219:947-958.

 

May VE, Ettle B, Poehler AM, Nuber S, Ubhi K, Rockenstein E, Winner B, Wegner M, Masliah E, Winkler J. alpha-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy. Neurobiol Aging 2014;35:2357-2368.

 

McKinley J, O'Connell M, Farrell M, Lynch T. Normal dopamine transporter imaging does not exclude multiple system atrophy. Parkinsonism Relat Disord 2014;20:933-934.

 

Meissner WG, Flabeau O, Perez P, Taillard J, Marquant F, Dupouy S, Tison F, Philip P, Ghorayeb I. Accuracy of portable polygraphy for the diagnosis of sleep apnea in multiple system atrophy. Sleep Med 2014;15:476-479.

 

Mills JD, Kim WS, Halliday GM, Janitz M. Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy. Neurogenetics 2015;16:107-122.

 

Miranda M, Walker RH, Bustamante ML. Electronic message ataxia in multiple system atrophy. Neurology 2014;83:1677.

 

Mitsui J, Tsuji S. Mutant COQ2 in multiple-system atrophy. N Engl J Med 2014;371:82-83.

 

Numao A, Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 2014;20:212-216.

 

Ogaki K, Fujioka S, Heckman MG, Rayaprolu S, Soto-Ortolaza AI, Labbe C, Walton RL, Lorenzo-Betancor O, Wang X, Asmann Y, Rademakers R, Graff-Radford N, Uitti R, Cheshire WP, Wszolek ZK, Dickson DW, Ross OA. Analysis of COQ2 gene in multiple system atrophy. Mol Neurodegener 2014;9:44.

 

Ota K, Obayashi M, Ozaki K, Ichinose S, Kakita A, Tada M, Takahashi H, Ando N, Eishi Y, Mizusawa H, Ishikawa K. Relocation of p25alpha/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy. Acta Neuropathol Commun 2014;2:136.

 

Ozawa T. The COQ2 mutations in Japanese multiple system atrophy: impact on the pathogenesis and phenotypic variation. Mov Disord 2014;29:184.

 

Ozawa T, Sone H, Nishizawa M. Reply to: Relationship between leptin and blood pressure in patients with multiple system atrophy. J Neurol Sci 2015;348:285.

 

Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Yokoseki A, Sone H, Nishizawa M. The circulating level of leptin and blood pressure in patients with multiple system atrophy. J Neurol Sci 2014;347:349-351.

 

Palma JA, Kaufmann H. Novel therapeutic approaches in multiple system atrophy. Clin Auton Res 2015;25:37-45.

 

Pan P. [Case of multiple system atrophy]. Zhongguo Zhen Jiu 2014;34:516.

 

Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J, Tienari PJ, Poyhonen M, Paetau A. Novel alpha-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson's disease-type pathology. Neurobiol Aging 2014;35:2180 e2181-2185.

 

Peeraully T. Multiple system atrophy. Semin Neurol 2014;34:174-181.

 

Picillo M, Barone P, Erro R, Spina E, Pellecchia MT. Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 2014;20:680-681.

 

Pilleri M, Levedianos G, Weis L, Gasparoli E, Facchini S, Biundo R, Formento-Dojot P, Antonini A. Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy. Parkinsonism Relat Disord 2014;20:217-221.

 

Planetta PJ, Kurani AS, Shukla P, Prodoehl J, Corcos DM, Comella CL, McFarland NR, Okun MS, Vaillancourt DE. Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy. Hum Brain Mapp 2015;36:1165-1179.

 

Poewe W, Seppi K, Fitzer-Attas CJ, Wenning GK, Gilman S, Low PA, Giladi N, Barone P, Sampaio C, Eyal E, Rascol O, Rasagiline-for MSAi. Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial. Lancet Neurol 2015;14:145-152.

 

Provitera V, Nolano M, Caporaso G, Stancanelli A, Manganelli F, Iodice R, Selim MM, De Rosa A, Lanzillo B, Pellecchia MT, De Michele G, Santoro L. Postganglionic sudomotor denervation in patients with multiple system atrophy. Neurology 2014;82:2223-2229.

 

Quinzii CM, Hirano M, DiMauro S. Mutant COQ2 in multiple-system atrophy. N Engl J Med 2014;371:81-82.

 

Ramirez EP, Vonsattel JP. Neuropathologic changes of multiple system atrophy and diffuse Lewy body disease. Semin Neurol 2014;34:210-216.

 

Reginold W, Lang AE, Marras C, Heyn C, Alharbi M, Mikulis DJ. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 2014;20:222-225.

 

Rey MV, Perez-Lloret S, Pavy-Le Traon A, Meissner WG, Tison F, Rascol O. A cross-sectional study on drug use in multiple system atrophy. CNS Drugs 2014;28:483-490.

 

Roncevic D, Palma JA, Martinez J, Goulding N, Norcliffe-Kaufmann L, Kaufmann H. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. J Neural Transm (Vienna) 2014;121:507-512.

 

Sakurai K, Imabayashi E, Ito K, Tokumaru AM, Ozawa Y, Muto M, Nakagawa M, Okita K, Matsukawa N, Shibamoto Y. The utility of cerebral perfusion SPECT analysis using SPM8, eZIS and vbSEE for the diagnosis of multiple system atrophy-parkinsonism. Ann Nucl Med 2015;29:206-213.

 

Salvesen L, Ullerup BH, Sunay FB, Brudek T, Lokkegaard A, Agander TK, Winge K, Pakkenberg B. Changes in total cell numbers of the basal ganglia in patients with multiple system atrophy - A stereological study. Neurobiol Dis 2015;74:104-113.

 

Scholz SW, Majounie E, Revesz T, Holton JL, Okun MS, Houlden H, Singleton AB. Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions. Neurobiol Aging 2015;36:1223 e1221-1222.

 

Schottlaender LV, Holton JL, Houlden H. Multiple system atrophy and repeat expansions in C9orf72. JAMA Neurol 2014;71:1190-1191.

 

Schottlaender LV, Houlden H, Multiple-System Atrophy Brain Bank C. Mutant COQ2 in multiple-system atrophy. N Engl J Med 2014;371:81.

 

Shao N, Yang J, Shang H. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation. Neurosci Lett 2015;587:79-86.

 

Sharma M, Wenning G, Kruger R, European Multiple-System Atrophy Study G. Mutant COQ2 in multiple-system atrophy. N Engl J Med 2014;371:80-81.

 

Shimohata T, Nakayama H, Aizawa N, Nishizawa M. Discontinuation of continuous positive airway pressure treatment in multiple system atrophy. Sleep Med 2014;15:1147-1149.

 

Shindo K, Onohara A, Hata T, Kobayashi F, Nagasaka K, Nagasaka T, Takiyama Y. Opsoclonus-myoclonus syndrome associated with multiple system atrophy. Cerebellum Ataxias 2014;1:15.

 

Silva-Batista C, Kanegusuku H, Roschel H, Souza EO, Cunha TF, Laurentino GC, Manoel N, Jr., De Mello MT, Piemonte ME, Brum PC, Forjaz CL, Tricoli V, Ugrinowitsch C. Resistance training with instability in multiple system atrophy: a case report. J Sports Sci Med 2014;13:597-603.

 

Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown RG, Burn DJ, Holton JL, Kaufmann H, Kostic VS, Ling H, Meissner WG, Poewe W, Semnic M, Seppi K, Takeda A, Weintraub D, Wenning GK, Movement Disorders Society MSASG. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Mov Disord 2014;29:857-867.

 

Stanzani-Maserati M, Gallassi R, Calandra-Buonaura G, Alessandria M, Oppi F, Poda R, Sambati L, Provini F, Cortelli P. Cognitive and sleep features of multiple system atrophy: review and prospective study. Eur Neurol 2014;72:349-359.

 

Sturm E, Stefanova N. Multiple system atrophy: genetic or epigenetic? Exp Neurobiol 2014;23:277-291.

 

Sun ZF, Xiang XS, Chen Z, Zhang L, Tang BS, Xia K, Jiang H. Increase of the plasma alpha-synuclein levels in patients with multiple system atrophy. Mov Disord 2014;29:375-379.

 

Sunwoo MK, Yun HJ, Song SK, Ham JH, Hong JY, Lee JE, Lee HS, Sohn YH, Lee JM, Lee PH. Mesenchymal stem cells can modulate longitudinal changes in cortical thickness and its related cognitive decline in patients with multiple system atrophy. Front Aging Neurosci 2014;6:118.

 

Suppa A, Marsili L, Di Stasio F, Latorre A, Parvez AK, Colosimo C, Berardelli A. Primary motor cortex long-term plasticity in multiple system atrophy. Mov Disord 2014;29:97-104.

 

Suwijn SR, Berendse HW, Verschuur CV, de Bie RM, Booij J. Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy. ISRN Neurol 2014;2014:345132.

 

Suzuki K, Numao A, Miyamoto M, Miyamoto T, Hirata K. Authors' reply to the comments of Picillo et al. regarding "Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy". Parkinsonism Relat Disord 2014;20:682-683.

 

Suzuki Y, Jin C, Iwase T, Yazawa I. beta-III Tubulin fragments inhibit alpha-synuclein accumulation in models of multiple system atrophy. J Biol Chem 2014;289:24374-24382.

 

Suzuki Y, Jin C, Yazawa I. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy. Am J Pathol 2014;184:790-799.

 

Tandon R, Pradhan S. Autonomic predominant multiple system atrophy in the context of Parkinsonian and cerebellar variants. Clin Neurol Neurosurg 2015;130:110-113.

 

Thavanesan N, Gillies M, Farrell M, Green AL, Aziz T. Deep brain stimulation in multiple system atrophy mimicking idiopathic Parkinson's disease. Case Rep Neurol 2014;6:232-237.

 

Tsuji S. [Susceptibility gene in multiple system atrophy (MSA)]. Rinsho Shinkeigaku 2014;54:969-971.

 

Ubhi K, Rockenstein E, Kragh C, Inglis C, Spencer B, Michael S, Mante M, Adame A, Galasko D, Masliah E. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. Eur J Neurosci 2014;39:1026-1041.

 

Valera E, Ubhi K, Mante M, Rockenstein E, Masliah E. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia 2014;62:317-337.

 

Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R, Weis L, Di Pietro C, De Iuliis A, Nicoletti A, Zappia M, Purrello M, Antonini A. Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy. Front Cell Neurosci 2014;8:156.

 

Wakabayashi K, Tanji K. [Multiple system atrophy and autophagy]. Rinsho Shinkeigaku 2014;54:966-968.

 

Wang Y, Shao WB, Gao L, Lu J, Gu H, Sun LH, Tan Y, Zhang YD. Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson's disease and multiple system atrophy--comparison with normal elderly. PLoS One 2014;9:e116123.

 

Watanabe H, Yoshida M, Sobue G. [Clinical picture and diagnostic criteria of multiple system atrophy]. Rinsho Shinkeigaku 2014;54:963-965.

 

Wenning GK, Krismer F, Poewe W. Rifampicin for multiple system atrophy. Lancet Neurol 2014;13:237-239.

 

Wong JH, Halliday GM, Kim WS. Exploring myelin dysfunction in multiple system atrophy. Exp Neurobiol 2014;23:337-344.

 

Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown R, Leigh PN, Simmons A. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. PLoS One 2014;9:e114167.

 

Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown RG, Leigh PN, Dell'Acqua F, Simmons A. Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One 2014;9:e112638.

 

Wu SH, Yang HX, Jiang GH, Gong DR, Wang LX. Preliminary results of cord blood mononuclear cell therapy for multiple system atrophy: a report of three cases. Med Princ Pract 2014;23:282-285.

 

Yamamoto T, Sakakibara R, Uchiyama T, Yamaguchi C, Ohno S, Nomura F, Yanagisawa M, Hattori T, Kuwabara S. Time-dependent changes and gender differences in urinary dysfunction in patients with multiple system atrophy. Neurourol Urodyn 2014;33:516-523.

 

Yang H, Wang X, Liao W, Zhou G, Li L, Ouyang L. Application of diffusion tensor imaging in multiple system atrophy: the involvement of pontine transverse and longitudinal fibers. Int J Neurosci 2015;125:18-24.

 

Yoon RG, Kim SJ, Kim HS, Choi CG, Kim JS, Oh J, Chung SJ, Lee CS. The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neurosci Lett 2015;584:296-301.

 

Yuan X, Chen Y, Cao B, Zhao B, Wei Q, Guo X, Yang Y, Yuan L, Shang H. An association analysis of the R1628P and G2385R polymorphisms of the LRRK2 gene in multiple system atrophy in a Chinese population. Parkinsonism Relat Disord 2015;21:147-149.

 

Zhang F, Chen J, Zhao L, Dong C. Candidate biomarkers of multiple system atrophy in cerebrospinal fluid. Rev Neurosci 2014;25:653-662.

 

Zhang PR, Guo GH, Gu WH, Zhang ZY, Wang K, Jin M. [Clinical effect of Yisui decoction plus western medicine in treating multiple system atrophy]. Zhongguo Zhong Yao Za Zhi 2014;39:2968-2971.

 

Zhang PR, Guo GH, Gu WH, Zhang ZY, Wang K, Jin M. [Clinical effect of Yisui decoction plus western medicine in treating multiple system atrophy]. Zhongguo Zhong Yao Za Zhi 2014;39:2968-2971.

 

Zhu XY, Pan TH, Ondo WG, Jimenez-Shahed J, Wu YC. Effects of deep brain stimulation in relatively young-onset multiple system atrophy Parkinsonism. J Neurol Sci 2014;342:42-44.

 

Zoetmulder M, Biernat HB, Nikolic M, Korbo L, Jennum PJ. Sensorimotor gating deficits in multiple system atrophy: comparison with Parkinson's disease and idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord 2014;20:297-302.